top of page


Our group has been an integral Clinical Research Site for the  AIDS Clinical Trials Group (ACTG) for HIV research since 1991 in close partnership with the University of North Carolina at Chapel Hill. Our staff and our patients have been an active part of the historical revolution in HIV care that the ACTG research has forged in the past several decades.


In addition to ACTG Trials, we are now enrolling in our first prevention study with Family Health International (FHI), HPTN083, which seeks to enroll MSM and transgender women who are at high risk of getting HIV. The Reprieve Study is also enrolling for HIV positive individuals at low risk for a cardiac event. It is an international study sponsored by the NIH studying to see if the addition of a statin drug helps prevent these events.


We are also currently involved in pharmaceutically sponsored research with Gilead Sciences evaluating the safety and efficacy of a new integrase-based regimen for HIV treatment. Past pharmaceutical studies included ARIA and Stribild (2 studies with ViiV/GSK) that compared Triumeq against other ARVS.


We will continue to explore further research opportunities and partnerships that further the cause of the scientific and medical understanding of HIV, with the goal of not only serving to help our current patients, but also for those in the future.


The Regional Center for Infectious Disease Clinical Trials Site is staffed by Kim Epperson, RN BSN, Elisha Epperson, RN BSN, Marlene Allen, BS, Lisa Dasnoit, RN BSN, Tamika Yarborough, BS and Bridget Thomas, MPH.  Phillip Bozovich,  PharmD of Bennett’s Pharmacy and Nita Johnston, PharmD of Moses Cone Hospital serve as clinical pharmacists to our study patients.  Medical leadership is provided by Site Leader, Cornelius (Kees) Van Dam, M.D. Administrative support is provided by Charles Hansen, MA, CCRC.


Clinical trials are a resource available to you if you are interested and meet the study requirements. Your participation is completely voluntary and does not affect your ability to receive any other care available in the clinic.


Some benefits of research may include:

  • Contributing to the science of HIV and working toward a cure

  • Getting study medications at no cost

  • Free physical exams, lab work and related tests

  • Receiving compensation to offset the time you spend on your visits


There are many research studies going on at the Regional Center for Infectious Disease. To find out more about research you can talk to your provider, your nurse or the clinical site coordinator, Kim Epperson, RN at 336-832-3262.


Some helpful resources related to research include:


Our Research Page on Facebook: RCID Research


AIDS Clinical Trials Group Network - a service of the US National Institutes of Health


The Start Study


HIV Prevention Trials Network








bottom of page